These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 17970082)
1. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma. Nakayama G; Hibi K; Kodera Y; Koike M; Fujiwara M; Nakao A Anticancer Res; 2007; 27(5A):3367-70. PubMed ID: 17970082 [TBL] [Abstract][Full Text] [Related]
2. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients. Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139 [TBL] [Abstract][Full Text] [Related]
3. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker. Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997 [TBL] [Abstract][Full Text] [Related]
4. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients. Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762 [TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161 [TBL] [Abstract][Full Text] [Related]
6. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319 [TBL] [Abstract][Full Text] [Related]
7. p16INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer. Nakayama G; Kodera Y; Ohashi N; Koike M; Fujiwara M; Nakao A Anticancer Res; 2011 May; 31(5):1643-6. PubMed ID: 21617221 [TBL] [Abstract][Full Text] [Related]
8. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival. Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748 [TBL] [Abstract][Full Text] [Related]
10. Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer. Sakamoto J; Fujiya M; Okamoto K; Nata T; Inaba Y; Moriichi K; Tanabe H; Mizukami Y; Watari J; Ashida T; Kohgo Y Cancer Epidemiol; 2010 Apr; 34(2):194-9. PubMed ID: 20129840 [TBL] [Abstract][Full Text] [Related]
11. Detection of TFPI2 methylation in the serum of colorectal cancer patients. Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798 [TBL] [Abstract][Full Text] [Related]
12. p16 Gene methylation in colorectal tumors: correlation with clinicopathological features and prognostic value. Sanz-Casla MT; Maestro ML; Vidaurreta M; Maestro C; Arroyo M; Cerdán J Dig Dis; 2005; 23(2):151-5. PubMed ID: 16352895 [TBL] [Abstract][Full Text] [Related]
13. [DNA methylation status of RARβ2 and p16(INK4α) in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma]. Wang CC; Mao WM; Ling ZQ Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):441-5. PubMed ID: 22967446 [TBL] [Abstract][Full Text] [Related]
14. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications. González-Quevedo R; García-Aranda C; Morán A; De Juan C; Sánchez-Pernaute A; Torres A; Díaz-Rubio E; Balibrea JL; Benito M; Iniesta P Int J Oncol; 2004 Feb; 24(2):349-55. PubMed ID: 14719111 [TBL] [Abstract][Full Text] [Related]
15. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa. Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187 [TBL] [Abstract][Full Text] [Related]
16. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer. Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196 [TBL] [Abstract][Full Text] [Related]
17. Vimentin methylation as a marker for advanced colorectal carcinoma. Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162 [TBL] [Abstract][Full Text] [Related]
18. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer. Hibi K; Nakao A Anticancer Res; 2006; 26(1A):55-8. PubMed ID: 16475679 [TBL] [Abstract][Full Text] [Related]
19. p16 gene methylation in colorectal cancers associated with Duke's staging. Yi J; Wang ZW; Cang H; Chen YY; Zhao R; Yu BM; Tang XM World J Gastroenterol; 2001 Oct; 7(5):722-5. PubMed ID: 11819863 [TBL] [Abstract][Full Text] [Related]
20. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]